0.00Open0.00Pre Close0 Volume0 Open Interest92.00Strike Price0.00Turnover103.13%IV-14.33%PremiumDec 13, 2024Expiry Date11.53Intrinsic Value100Multiplier2DDays to Expiry0.00Extrinsic Value100Contract SizeAmericanOptions Type-0.9635Delta0.0140Gamma6.94Leverage Ratio-0.0693Theta-0.0032Rho-6.68Eff Leverage0.0046Vega
DexCom Stock Discussion
Revenue came in at $994.2 million, topping the forecast of $990.71 million and showing growth from last year's $975 million.
The company announced that Teri Lawver, EVP and Chief Commercial Officer, will retire by year-end, with CEO Kevin Sayer temporarily leading the commercial team.
DexCom reaffirmed its 2024 sales outl...
No comment yet